CLARMA CAPITAL focuses on investing in European life sciences startups, particularly those at the forefront of medical device, medicinal product, and diagnostic innovation. Our team, located in London, Switzerland, Dublin, and Central Europe, is committed to nurturing breakthroughs in this dynamic sector.
Through early-stage investments, we aim to drive substantial growth and propel transformative change in healthcare. With a strategic approach, we navigate opportunities for impactful innovation while maintaining a clear vision for successful exits.
We prioritize businesses with clearly differentiated products, working in collaboration
with management teams to support the achievement of a company’s short-term and
long-term business goals.
Assisting portfolio companies in securing follow-on funding including intros to VCs and other investors
Strategic Partnerships
Facilitating strategic partnerships and collaborations with other life sciences companies, hospitals, research institutes & industry stakeholders
Operational Efficiency
Helping companies improve their operational processes, cost management and scalability
Our Latest Updates and Developments
In the ever-changing world of healthcare investing, essential indicators of success include an
acute awareness of market fluctuations, emerging sectors, regulatory shifts,
and global economic indicators.
Please note that references to ‘Clarma Capital Ltd’ encompass the activities and operations of Clarma Capital GP Limited and Clarma Capital Fund I Limited Partnership. ‘Clarma Capital Ltd’ is used for branding and convenience purposes only and does not represent a separate legal entity registered with the Irish authorities.